Douglas Kemp-Welch
CEO @Berkeley Biopharma
Signup · Get unlimited contacts
WORK HISTORY
CEO @Berkeley Biopharma
CA
Berkeley BioPharma specializes in the development, marketing/licensing and distribution of solid oral dose controlled release ( up to 12 hours) tablet formulations of cannabis compounds targeted at the rapidly growing North American medicinal marijuana market. Berkeley has formulated a complete product of cannabis based products that avoids the adverse effects of smoking and edibles while providing the medical community and insurance companies with a fixed oral dose product to better prescribe cannabis for the mainstream treatment of chronic pain and other maladies.
EDUCATION
University of Toronto - Rotman School of Management
ICD.D, Corpoate Governance
Queen's University
MBA, Business Admin
ABOUT DOUGLAS KEMP-WELCH
Senior Executive, Capital Markets Advisor, Director, Investor, Corporate Due Diligence
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.